University of Iowa Researcher Named Editor-in-Chief of Cardiovascular Genomics Journal

The American Heart Association has appointed Dr. Ferhaan Ahmad as the new editor-in-chief of Circulation: Genomic and Precision Medicine, marking a significant leadership transition in the specialized field of cardiovascular genomics research. Ahmad, who serves as the founding director of the Cardiovascular Genomics Program at the University of Iowa Carver College of Medicine, brings extensive expertise in genetic mechanisms underlying cardiovascular disorders.

With a multifaceted academic background including medical and doctoral degrees from McGill University and Baylor College of Medicine, Ahmad has established himself as a leading researcher in cardiovascular genetics. His research focuses on understanding genetic and genomic mechanisms in inherited cardiovascular conditions such as hypertrophic cardiomyopathy, dilated cardiomyopathy, and inherited arrhythmias.

In his new role, Ahmad aims to broaden the journal's scientific scope and impact. His strategic vision includes encouraging collaborative engagement across medical disciplines, increasing representation of researchers from diverse backgrounds, and incorporating patient and family perspectives into scientific dialogue. Specifically, he plans to elevate research in implementation science, community-engaged research, and studies addressing health equity.

Ahmad's appointment represents a critical moment for cardiovascular genomics, a rapidly evolving field with significant potential to transform medical understanding and treatment of heart-related conditions. By championing inclusive research practices and interdisciplinary collaboration, he seeks to accelerate scientific discoveries that can ultimately improve patient care and outcomes.

The new editor-in-chief brings a decade of editorial experience from the Journal of the American Heart Association and leadership roles in multiple American Heart Association councils. His comprehensive approach emphasizes translating genetic research findings into practical medical applications, addressing critical gaps in understanding cardiovascular disease mechanisms.